Comparison of Four Methods for Entering the Gap Position of Landolt Cs (LC_Entry)

July 19, 2023 updated by: Aalen University

Comparison of Four Methods for Entering the Gap Position of Landolt Cs With Respect to Validity, Retest Reliability, Examination Duration and Test Subject Satisfaction

The aim of this study is to investigate and compare the validity of four different input methods for Landolt Cs, i.e. the proportion of correct gap positions in relation to the total number of performances. The four input methods are a numeric keypad, an eight-positions rocker switch, a remote control and voice feedback.

Study Overview

Status

Completed

Detailed Description

The measurement of visual acuity is the most frequent and one of the most important ophthalmological functional investigations. Therefore, it is particularly important to find a measuring procedure with as little input errors as possible.

The 8-position Landolt C (LC) is the internationally accepted, well-standardised optotype for the determination of visual acuity.

Usually, the subjects informs the examiner verbally about the perceived position of each LC. According to the current literature, about 20 to 30 % of the population suffers from a right/left weakness. Furthermore, language barriers are an additional considerable hurdle.

Therefore, it is important to find an input method for the LC gap positions with minimal entry mistakes. In oder to avoid the thresholding procedure and its inherent difficulties, highly supra-threshold (10 times above the previously determined individual central visual acuity threshold) 8-position LCs are presented.

The study compares four input methods for entering of the Landolt C gap positions: a modified numeric keypad, an 8-position rocker switch, a modified TV remote control and voice/verbal feedback.

Each subject will perform all four input methods, with 2 test runs of 16 Landolt C presentations, each. A forced-choice method will be applied, i.e. the test is not continued until the test person has responded ot each single presentation. Regardless of whether the entry was correct or incorrect, the next Landolt C is displayed.

The optotypes are presented using modified version of the Freiburg Visual Acuity and Contrast Test (FrACT), which allows to present the 8-position Landolt Cs in a standardized way on a video display unit (VDU).

The sequence of the input methods is randomized. This study is carried out in a "within-subject design", i.e. all test persons go through all test conditions and serve as their own controls.

Study Type

Observational

Enrollment (Actual)

24

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Deutschland
      • Aalen, Deutschland, Germany, 73430
        • Ulrich SCHIEFER

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy, young subjects recruited for the students and or co-workers of the Aalen University of Applied Sciences

Description

Inclusion Criteria:

  • Age: ≥ 18 years
  • Informed consent
  • (Distance) visual acuity with best correction: ≥ 0.8
  • (Distant) ametropia: ≤+8.0 Diopters (spherical equivalent)
  • Anisometropia ≤ 3 dpt
  • Astigmatism ≤ 2.5 dpt

Exclusion Criteria:

  • Prolonged reaction time caused by drugs (medications)/ drugs/alcohol
  • Movement disorders (of hands) such as Parkinson's disease
  • Indication of amblyopia (strabismus surgery, occlusion therapy etc.)
  • Eye movement disorders/double vision
  • Defective stereo vision (according to LANG [I] stereo test)
  • Presence of a relative afferent pupil defect ("swinging flashlight test)
  • Any hint of visual pathway lesion or other chronic or progressive eye disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
validity
Time Frame: Through study completion, an average of 3 months
Proportion of correct gap position entries in relation to the total number of LC presentations by the four different entry methods
Through study completion, an average of 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
retest reliability
Time Frame: Through study completion, an average of 3 months
Comparison of the correct gap position entry between first and second test run by the four different entry methods
Through study completion, an average of 3 months
Examination duration
Time Frame: Through study completion, an average of 3 months
Comparison of the examination duration of the the four different entry methods and by the first and second run
Through study completion, an average of 3 months
Subjects´ satisfaction
Time Frame: Through study completion, an average of 3 months
Subjects´ evaluation (using a questionnaire) for the four different entry methods
Through study completion, an average of 3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ulrich Schiefer, M.D., +49 7361 576-4605

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 22, 2022

Primary Completion (Actual)

March 1, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

March 1, 2020

First Submitted That Met QC Criteria

March 6, 2020

First Posted (Actual)

March 9, 2020

Study Record Updates

Last Update Posted (Actual)

July 20, 2023

Last Update Submitted That Met QC Criteria

July 19, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Validation Study

Clinical Trials on Landolt C entry method

Subscribe